Saturday 17 October 2026
Export MLAB’s income statement to Excel — free account
Mesa Laboratories, Inc.
MLAB Technology Scientific & Technical Instruments
Mesa Laboratories, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $249.1 million, up 3.38% from fiscal 2025. In the quarter to June 2026, revenue grew 1.00%, EPS fell 42.5%, free cash flow grew 1,503.7% and total debt rose 70.6%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
122.48
5.26
−4.12%
Follow MLAB
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
71.89 | 0.00 | 0.00 | 1,027.82 | 688.86 | 392.74 | 471.02 | 117.38 | 0.00 | 40.50 |
Piotroski F-Score |
7 | 6 | 4 | 7 | 4 | 7 | 4 | 7 | 4 | 4 |
P/S ratio |
1.96 | 2.67 | 2.79 | 4.24 | 7.21 | 9.04 | 8.07 | 8.52 | 5.58 | 4.82 |
Altman Z-Score |
1.45 | 1.31 | (0.75) | 2.72 | 3.11 | 4.72 | 3.90 | 13.27 | 6.51 | 5.26 |
P/FCF ratio |
12.32 | 15.11 | 14.51 | 39.67 | 38.18 | 34.53 | 37.23 | 27.88 | 22.32 | 79.21 |
Altman Z″-Score (non-manufacturers) |
0.37 | (1.48) | (3.97) | 2.69 | 2.42 | 5.67 | 3.48 | 4.93 | 3.64 | 4.16 |
P/Operating CF |
34.92 | 50.79 | 46.82 | 74.27 | 142.81 | 89.60 | 107.52 | 85.63 | 55.68 | 42.86 |
Beneish M-Score |
(2.80) | (2.79) | (6.03) | (2.68) | (1.83) | (2.74) | (2.36) | (3.20) | (3.32) | (2.64) |
P/B ratio |
2.62 | 4.02 | 4.15 | 2.36 | 3.37 | 2.98 | 4.32 | 7.89 | 5.40 | 4.61 |
Dividend Safety Score |
67 | — | — | — | — | — | — | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.06 | 0.00 | 75.01 | 0.00 | 0.00 |
EV/Sales |
2.46 | 2.89 | 3.70 | 4.94 | 8.14 | 8.17 | 8.58 | 8.64 | 6.02 | 5.36 |
EV/EBITDA |
14.65 | 16.55 | 22.67 | 29.71 | 97.25 | 36.99 | 34.32 | 37.16 | 22.73 | 20.05 |
EV/Operating CF |
14.29 | 14.88 | 18.12 | 38.70 | 38.25 | 29.52 | 37.41 | 29.17 | 22.51 | 29.03 |
EV/FCF |
15.46 | 16.37 | 19.23 | 46.20 | 43.12 | 31.19 | 39.58 | 28.28 | 24.07 | 88.13 |
Quick Ratio |
1.15 | 0.42 | 1.52 | 1.74 | 1.88 | 8.83 | 3.94 | 0.96 | 1.14 | 1.22 |
Current Ratio |
1.72 | 0.63 | 2.47 | 2.74 | 2.59 | 9.32 | 4.72 | 1.42 | 1.85 | 2.16 |
Net Debt/EBITDA |
2.98 | 1.27 | 5.49 | 4.20 | 11.14 | (3.96) | 2.04 | 0.52 | 1.60 | 1.96 |
Debt/Assets |
35.41% | 18.61% | 49.62% | 28.12% | 31.26% | 24.39% | 34.56% | 14.50% | 28.19% | 31.91% |
Debt/Equity |
0.81 | 0.50 | 1.52 | 0.47 | 0.56 | 0.36 | 0.64 | 0.20 | 0.47 | 0.56 |
Asset Turnover |
0.58 | 0.55 | 0.39 | 0.32 | 0.28 | 0.27 | 0.42 | 0.64 | 0.57 | 0.56 |
Operating CF/Net income |
6.38 | (23.71) | (0.17) | 30.09 | 20.96 | 11.32 | 15.18 | 4.08 | (8.68) | 1.55 |
Capex/Depreciation |
(0.14) | (0.17) | (0.01) | (0.14) | (0.41) | (0.12) | (0.07) | 0.07 | (0.07) | (1.33) |
Interest Coverage |
1.73 | 1.38 | (47.76) | 0.70 | 1.21 | 1.54 | 1.44 | 5.59 | 1.18 | — |
| 3.88% | (1.29%) | (94.36%) | 0.24% | 0.47% | 1.05% | 1.07% | 7.10% | (3.00%) | 12.26% | |
| 1.56% | (0.45%) | (45.87%) | 0.14% | 0.29% | 0.65% | 0.63% | 4.66% | (1.76%) | 6.73% | |
ROIC |
3.72% | 4.79% | (50.18%) | 0.38% | 0.52% | 2.67% | 1.77% | 4.94% | 0.97% | 6.95% |
Return on Tangible Assets |
8.95% | 6.82% | (262.63%) | 0.90% | 1.78% | 1.12% | 1.50% | 23.25% | (7.74%) | 24.73% |
Average Days of Receivables |
64.61 | 63.57 | 65.94 | 70.89 | 81.63 | 64.82 | 65.54 | 44.29 | 54.28 | 55.80 |
Research and Development Expense of Revenue |
8.15% | 8.10% | 8.93% | 9.35% | 8.55% | 7.76% | 5.40% | 3.40% | 3.68% | 4.44% |
Selling, General and Administrative Expense of Revenue |
47.95% | 47.73% | 51.57% | 50.16% | 48.08% | 47.98% | 43.41% | 38.35% | 36.47% | 34.99% |
Intangible Assets out of Total Assets |
0.63 | 0.64 | 0.66 | 0.76 | 0.77 | 0.45 | 0.64 | 0.64 | 0.66 | 0.64 |
Share Based Compensation of Revenue |
7.17% | 5.45% | 5.52% | 5.72% | 6.18% | 6.92% | 4.69% | 4.08% | 1.74% | 1.51% |
Graham Net Nets |
(0.28) | (0.27) | (0.32) | (0.16) | (0.14) | 0.09 | (0.07) | (0.01) | (0.06) | (0.08) |
Graham Number |
30.57 | 0.00 | 0.00 | 16.82 | 25.08 | 33.75 | 23.79 | 35.67 | 0.00 | 42.58 |
Earnings Yield |
1.39% | (0.30%) | (42.09%) | 0.10% | 0.15% | 0.25% | 0.21% | 0.85% | (0.54%) | 2.47% |
Free Cash Flow Yield |
8.12% | 6.62% | 6.89% | 2.52% | 2.62% | 2.90% | 2.69% | 3.59% | 4.48% | 1.26% |
Revenue per Share |
45.18 | 44.45 | 40.14 | 41.17 | 35.37 | 26.92 | 28.02 | 26.87 | 25.51 | 25.46 |
Operating CF per Share |
7.77 | 8.63 | 8.19 | 5.26 | 7.53 | 7.45 | 6.43 | 7.96 | 6.82 | 4.70 |
Capex per Share |
(0.59) | (0.83) | (0.48) | (0.85) | (0.85) | (0.40) | (0.35) | 0.25 | (0.44) | (3.15) |
Free Cash Flow per Share |
7.18 | 7.80 | 7.72 | 4.41 | 6.68 | 7.05 | 6.07 | 8.21 | 6.38 | 1.55 |
Cash per Share |
4.88 | 5.04 | 5.24 | 6.18 | 9.47 | 53.04 | 19.38 | 2.65 | 1.45 | 1.58 |
Shareholders Equity per Share |
33.78 | 29.48 | 26.99 | 73.95 | 75.56 | 81.65 | 52.38 | 28.99 | 26.36 | 26.59 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
33.78 | 29.48 | 26.99 | 73.95 | 75.56 | 81.65 | 52.38 | 28.99 | 26.36 | 26.59 |
Free Cash Flow |
39.58 | 42.31 | 41.57 | 23.44 | 34.79 | 35.08 | 25.51 | 31.51 | 24.05 | 5.70 |
Working Capital |
44.37 | (61.28) | 65.04 | 75.62 | 76.26 | 271.17 | 96.78 | 9.96 | 14.70 | 19.22 |
Capital Expenditures |
(3.25) | (4.50) | (2.57) | (4.54) | (4.43) | (1.99) | (1.48) | 0.96 | (1.67) | (11.60) |
Net Current Asset Value |
(135.23) | (170.83) | (192.05) | (149.38) | (189.25) | 108.50 | (66.30) | (11.83) | (32.75) | (38.13) |
EV/EBIT |
33.07 | 42.64 | 0.00 | 326.20 | 319.06 | 88.55 | 127.42 | 91.11 | 265.24 | 30.79 |
Capex to Sales |
0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | (0.01) | 0.02 | 0.12 |
Price to Operating Income |
26.34 | 39.38 | 0.00 | 280.04 | 282.53 | 98.03 | 119.85 | 89.84 | 245.92 | 27.67 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.76 | 0.80 | 9.68 | 1.18 | 0.37 | 0.78 | 0.97 | 0.64 | 0.99 | 0.34 |
Cash ROIC |
10.85% | 15.80% | 10.51% | 3.83% | 5.24% | 4.29% | 5.76% | 21.85% | 15.92% | 3.60% |
Accounts Receivable Turnover |
5.79 | 5.95 | 5.30 | 5.23 | 5.67 | 5.96 | 7.00 | 7.69 | 6.72 | 6.32 |
Accounts Payable Turnover |
17.02 | 15.29 | 13.62 | 12.17 | 12.17 | 11.91 | 16.60 | 16.00 | 18.28 | 16.20 |
Inventory Turnover |
3.51 | 3.11 | 2.46 | 2.88 | 4.21 | 3.69 | 4.98 | 5.28 | 3.60 | 2.90 |
Average Days of Payables |
19.80 | 23.28 | 26.59 | 26.22 | 38.31 | 34.79 | 23.77 | 25.05 | 20.90 | 19.57 |
Days of Inventory on Hand |
105.94 | 102.75 | 143.80 | 148.08 | 119.36 | 86.95 | 99.26 | 58.55 | 81.04 | 125.26 |
Average Receivables |
43.03 | 40.51 | 40.80 | 41.89 | 32.51 | 22.46 | 16.82 | 13.41 | 14.31 | 14.82 |
Average Payables |
5.34 | 5.89 | 6.09 | 7.02 | 6.19 | 3.94 | 3.15 | 2.64 | 2.27 | 2.50 |
Average Inventory |
25.87 | 29.02 | 33.66 | 29.62 | 17.89 | 12.70 | 10.50 | 8.00 | 11.55 | 13.95 |
Average Assets |
430.55 | 440.07 | 554.31 | 684.60 | 654.42 | 505.29 | 282.94 | 160.43 | 167.92 | 166.24 |
Average Common Equity |
173.04 | 152.61 | 269.44 | 393.64 | 400.01 | 313.12 | 165.66 | 105.34 | 98.59 | 91.25 |
Columns are period end dates